Literature DB >> 16466895

A simple and low-cost paper-bridged method for Salmonella phase reversal.

Chien-Shun Chiou1, Jim-Fung Huang, Li-Hsu Tsai, Kuei-Mao Hsu, Chun-Sing Liao, Hsiu-Li Chang.   

Abstract

We have developed a simple, rapid, and low-cost "paper-bridged" method for Salmonella phase reversal. More than 3500 isolates were tested in our laboratory, and the results indicated that this paper-bridged method is a useful alternative for phase reversal.

Mesh：

Substances：

Year:  2006        PMID： 16466895     DOI： 10.1016/j.diagmicrobio.2005.10.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  4 in total

1.  Overexpression of the recA gene decreases oral but not intraperitoneal fitness of Salmonella enterica.

Authors:  Laura Medina-Ruiz; Susana Campoy; Cristina Latasa; Paula Cardenas; Juan Carlos Alonso; Jordi Barbé
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Characterization of 13 multi-drug resistant Salmonella serovars from different broiler chickens associated with those of human isolates.

Authors:  Lan-Ho Chiu; Cheng-Hsun Chiu; Yan-Ming Horn; Chien-Shun Chiou; Chien-Yu Lee; Chia-Ming Yeh; Chang-You Yu; Chean-Ping Wu; Chao-Chin Chang; Chishih Chu
Journal:  BMC Microbiol       Date:  2010-03-23       Impact factor: 3.605

3.  Clonal dissemination of the multi-drug resistant Salmonella enterica serovar Braenderup, but not the serovar Bareilly, of prevalent serogroup C1 Salmonella from Taiwan.

Authors:  Chien-Shun Chiou; Jui-Ming Lin; Cheng-Hsun Chiu; Chi-Hong Chu; Shu-Wun Chen; Yung-Fu Chang; Bor-Chun Weng; Jwu-Guh Tsay; Chyi-Liang Chen; Chien-Hsing Liu; Chishih Chu
Journal:  BMC Microbiol       Date:  2009-12-17       Impact factor: 3.605

4.  Prevalence and Characterization of Monophasic Salmonella Serovar 1,4,[5],12:i:- of Food Origin in China.

Authors:  Xiaojuan Yang; Qingping Wu; Jumei Zhang; Jiahui Huang; Weipeng Guo; Shuzhen Cai
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.